skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Drug development and manufacturing

Abstract

X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.

Inventors:
; ;
Issue Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1223103
Patent Number(s):
9,157,875
Application Number:
10/880,388
Assignee:
Warner; Benjamin P.
DOE Contract Number:  
W-7405-ENG-36
Resource Type:
Patent
Resource Relation:
Patent File Date: 2004 Jun 29
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats

Warner, Benjamin P., McCleskey, T. Mark, and Burrell, Anthony K. Drug development and manufacturing. United States: N. p., 2015. Web.
Warner, Benjamin P., McCleskey, T. Mark, & Burrell, Anthony K. Drug development and manufacturing. United States.
Warner, Benjamin P., McCleskey, T. Mark, and Burrell, Anthony K. Tue . "Drug development and manufacturing". United States. https://www.osti.gov/servlets/purl/1223103.
@article{osti_1223103,
title = {Drug development and manufacturing},
author = {Warner, Benjamin P. and McCleskey, T. Mark and Burrell, Anthony K.},
abstractNote = {X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {10}
}

Patent:

Save / Share:

Works referenced in this record:

Quantitation of antibody binding to cell surface antigens by X-ray fluorescence spectrometry
journal, March 1979

  • Goldin, Eric M.; Corry, Peter M.; Granatek, Christine H.
  • Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 552, Issue 1, p. 120-128
  • DOI: 10.1016/0005-2736(79)90251-7

Micro-X-ray Fluorescence as a General High-Throughput Screening Method for Catalyst Discovery and Small Molecule Recognition
journal, May 2003

  • Miller, Thomasin C.; Mann, Grace; Havrilla, George J.
  • Journal of Combinatorial Chemistry, Vol. 5, Issue 3
  • DOI: 10.1021/cc020102g

Quantification of Pt bound to DNA using total-reflection X-ray fluorescence (TXRF)
journal, January 1999

  • Fernández Ruiz, R.; Tornero, J. D.; González, V. M.
  • The Analyst, Vol. 124, Issue 4
  • DOI: 10.1039/A900725C

Protein Microarrays to Detect Protein–Protein Interactions Using Red and Green Fluorescent Proteins
journal, July 2002

  • Kukar, Thomas; Eckenrode, Sarah; Gu, Yunrong
  • Analytical Biochemistry, Vol. 306, Issue 1
  • DOI: 10.1006/abio.2002.5614

Developing a Strategy for Activity-Based Detection of Enzymes in a Protein Microarray
journal, March 2003

  • Chen, Grace Y. J.; Uttamchandani, Mahesh; Zhu, Qing
  • ChemBioChem, Vol. 4, Issue 4, p. 336-339
  • DOI: 10.1002/cbic.200390054

Proteomics in drug discovery
journal, August 2002


Novel detection strategies for drug discovery
journal, September 2002


Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
journal, January 2002

  • Ulrich, Roger; Friend, Stephen H.
  • Nature Reviews Drug Discovery, Vol. 1, Issue 1
  • DOI: 10.1038/nrd710

The theoretical derivation of fluorescent X-ray intensities from mixtures
journal, January 1955


Quantitative Structure–Activity Relationship Methods: Perspectives on drug Discovery and Toxicology
journal, January 2003

  • Perkins, Roger; Fang, Hong; Tong, Weida
  • Environmental Toxicology and Chemistry, Vol. 22, Issue 8
  • DOI: 10.1897/01-171

Quantitative structure–activity relationships (QSARs) in toxicology: a historical perspective
journal, March 2003

  • Schultz, T. Wayne; Cronin, Mark T. D.; Walker, John D.
  • Journal of Molecular Structure: THEOCHEM, Vol. 622, Issue 1-2, p. 1-22
  • DOI: 10.1016/S0166-1280(02)00614-0

The Use of a Scanning X-ray Microprobe for Simultaneous XRF/XRD Studies of Fly-Ash Particles
journal, July 1997


Micro-X-ray Fluorescence as a General High-Throughput Screening Method for Catalyst Discovery and Small Molecule Recognition
journal, May 2003

  • Miller, Thomasin C.; Mann, Grace; Havrilla, George J.
  • Journal of Combinatorial Chemistry, Vol. 5, Issue 3
  • DOI: 10.1021/cc020102g

Protein chip technology
journal, February 2003


Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
journal, January 2002

  • Ulrich, Roger; Friend, Stephen H.
  • Nature Reviews Drug Discovery, Vol. 1, Issue 1
  • DOI: 10.1038/nrd710

Evaluation of the protein concentration in enzymes via determination of sulfur by total reflection X-ray fluorescence spectrometry — limitations of the method
journal, November 2001

  • Mertens, M.; Rittmeyer, C.; Kolbesen, B. O.
  • Spectrochimica Acta Part B: Atomic Spectroscopy, Vol. 56, Issue 11, p. 2157-2164
  • DOI: 10.1016/S0584-8547(01)00294-4